References
- Fields WS, Hass WK. eds. Aspirin, platelets, and stroke: background for a clinical trial. St Louis: WH Green, 1971: vii–ix, 3–6, 51–8
- Hass WK. Aspirin for the limping brain. (Editorial) Stroke 1977: 8(3): 299–301
- Dyken ML. Anticoagulant and platelet-antiaggregating therapy in stroke and threatened stroke. Neurol Clin 1983: 1(1): 223–42
- The Canadian Cooperative Study Group. randomized trial of aspirin and sulfinpyrazone in threatened stroke. N Engl J Med 1978: 299(2): 53–9
- Sorensen PS, Pedersen H, Marquardsen J, et al. Acetylsalicylic acid in the prevention of stroke in patients with reversible cerebral ischemic attacks: a Danish cooperative study. Stroke 1983: 14(1): 15–22
- Bousser MG, Eachwege E, Haguenau M, et al. “AICLA” controlled trial of aspirin and dipyridamole in the secondary prevention of athero-thrombotic cerebral ischemia. Stroke 1983: 14(1): 5–14
- The American-Canadian Co-Operative Stody group. Persantine Aspirin Trial in cerebral ischemia, n. Endpoint results. Stroke 1985: 16(3): 406–15
- The European Stroke Prevention Study Group. The European Stroke Prevention Study (ESPS): principal end-points. Lancet 1987: 2(8572): 1351–4
- UK-TIA Study Group. United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: interim results. BMJ (Clin Res) 1988: 296(6618): 316–20
- Gent M, Blakely JA, Easton JD, et al The Canadian-American Ticlopidine Study (CATS) in thromboembolic stroke: results of a North American randomized trial. Lancet 1989: 1: 1215–20
- Finding from the aspirin component of the ongjlng Physicians Health Study. N Engl J Med 1988: 318(4): 262–4
- Peto R, Gray R, Collins R, et al. Randomised trial of prophylactic daily aspirin to British male doctors. BMJ (Clin Res) 1988: 296(6618): 313–6
- Hennekens CH, Peto R, Hutchison OB, et al. An overview of the British and American aspirin studies. (letter) N Engl J Med 1988: 318(14): 923–4
- Duke RJ, Bloch RF, Turpie AG, et al. Intravenous heparin for the prevention of stroke progression to acute partial stable stroke. Ann totem Med 1986: 105(6): 825–8
- Keit DS, Phillips SJ, Whisnant JP, et al. Heparin therapy for recent transient focal cerebral Ischemia. Mayo Ota Proc 1987: 62(12): 1101–6 [erratum. Mayo din Proc 1988: 63(1): 92]
- Biller J, Bruno A, Adams HP Jr, et al. A randomized trial of aspirin or heparin in hospitalized patients with recent transient ischemic attacks: a pilot study. Stroke 1989: 20(4): 441–7
- Cerebral Embolism Task Force. Cardiogenic brain embolism. Arch Neurol 1986: 43(1): 71–84
- Petersen P, Boysen G, Godtfredsen J, et al. Addendum Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications to chronic atrial fibrillation: the Copenhagen AFASAK study. Lancet 1989: 1(8631): 175–9
- Bauer RB, Meyer JS, Fields WS, et al. Joint Study of Extracranial Arterial Occlusion. 3. Progress report of controlled study of long-term survival in patients with and without operation. JAMA 1969: 208(3): 509–18
- The EC/IC Bypass Study Group. Failure of extracranial-intracranial arterial bypass to reduce the risk of ischemic stroke: results of an international randomized trial. N Engl J Med 1985: 313(19): 1191–200
- Gent M. Single studies and overview analyses: Is aspirin of value in cerebral Ischemia? Stroke 1987: 18(3): 541–4
- Jonas S. Anticoagulant therapy in cerebrovascular disease: review and meta-analysis. Stroke 1968: 19(8): 1043–8 [erratum. Stroke 1989; 20(4): 562]
- Hass WK, Easton JD, Adams HP Jr. et al A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients. Ticlopidine Aspirin Stroke Study Group. N Engl J Med 1989: 321(8): 501–7
- Cerebral Embolism Task Farce. Cardiogenic brain embolism: the second report of the Cerebral Embolism Task Force. Arch Neural 1989: 46(7): 727–43